UroGen Pharma Ltd. Basic Shares Outstanding (Weighted Average)
UroGen Pharma Ltd. (URGN) reported Basic Shares Outstanding (Weighted Average) of 50.38 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-05
- UroGen Pharma Ltd. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 50.38M shares, a 5.53% increase year-over-year.
- UroGen Pharma Ltd. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 50.18M shares, a 5.82% increase year-over-year.
- UroGen Pharma Ltd. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 49.24M shares, a 4.69% increase year-over-year.
- UroGen Pharma Ltd. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 48.06M shares, a 2.73% increase year-over-year.
- UroGen Pharma Ltd. weighted average number of shares outstanding, basic for fiscal 2025 was 48.12M shares, a 12.22% increase from fiscal 2024.
- UroGen Pharma Ltd. weighted average number of shares outstanding, basic for fiscal 2024 was 42.88M shares, a 48.70% increase from fiscal 2023.
- UroGen Pharma Ltd. weighted average number of shares outstanding, basic for fiscal 2023 was 28.83M shares, a 26.43% increase from fiscal 2022.
- UroGen Pharma Ltd. weighted average number of shares outstanding, basic for fiscal 2022 was 22.81M shares, a 2.06% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 50.38M shares 10-Q · filed 2026-08-05 | 50.28M shares 10-Q · filed 2026-08-05 | 49.93M shares derived: average of 3 quarters · filed 2026-08-05 | 49.46M shares derived: average of 4 quarters · filed 2026-08-05 | |||
| 2026-03-31 | 50.18M shares 10-Q · filed 2026-05-06 | 49.71M shares derived: average of 2 quarters · filed 2026-05-06 | 49.16M shares derived: average of 3 quarters · filed 2026-05-06 | 48.80M shares derived: average of 4 quarters · filed 2026-08-05 | |||
| 2025-12-31 | 49.24M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | 48.65M shares derived: average of 2 quarters · filed 2026-03-02 | 48.34M shares derived: average of 3 quarters · filed 2026-08-05 | 48.12M shares 10-K · filed 2026-03-02 | |||
| 2025-09-30 | 48.06M shares 10-Q · filed 2025-11-06 | 47.90M shares derived: average of 2 quarters · filed 2026-08-05 | 47.74M shares 10-Q · filed 2025-11-06 | 47.56M shares derived: average of 4 quarters · filed 2026-08-05 | |||
| 2025-06-30 | 47.74M shares 10-Q · filed 2026-08-05 | 47.58M shares 10-Q · filed 2026-08-05 | 47.40M shares derived: average of 3 quarters · filed 2026-08-05 | 47.24M shares derived: average of 4 quarters · filed 2026-08-05 | |||
| 2025-03-31 | 47.42M shares 10-Q · filed 2026-05-06 | 47.23M shares derived: average of 2 quarters · filed 2026-05-06 | 47.08M shares derived: average of 3 quarters · filed 2026-05-06 | 45.43M shares derived: average of 4 quarters · filed 2026-05-06 | |||
| 2024-12-31 | 47.03M shares 10-K · filed 2025-03-10 | 46.91M shares derived: average of 2 quarters · filed 2025-11-06 | 44.77M shares derived: average of 3 quarters · filed 2025-11-06 | 42.88M shares 10-K · filed 2026-03-02 | |||
| 2024-09-30 | 46.78M shares 10-Q · filed 2025-11-06 | 43.10M shares 10-Q · filed 2024-11-06 | 43.64M shares derived: average of 2 quarters · filed 2025-11-06 | 41.48M shares 10-Q · filed 2025-11-06 | 37.80M shares 10-Q · filed 2024-11-06 | 40.12M shares derived: average of 4 quarters · filed 2025-11-06 | |
| 2024-06-30 | 40.50M shares 10-Q · filed 2025-08-07 | 36.82M shares 10-Q · filed 2024-08-13 | 38.79M shares 10-Q · filed 2025-08-07 | 35.11M shares 10-Q · filed 2024-08-13 | 37.90M shares derived: average of 3 quarters · filed 2025-08-07 | 36.50M shares derived: average of 4 quarters · filed 2025-08-07 | |
| 2024-03-31 | 37.06M shares 10-Q · filed 2025-05-12 | 33.38M shares 10-Q · filed 2024-05-13 | 36.61M shares derived: average of 2 quarters · filed 2025-05-12 | 35.17M shares derived: average of 3 quarters · filed 2025-05-12 | 32.24M shares derived: average of 4 quarters · filed 2025-05-12 | ||
| 2023-12-31 | 36.15M shares 10-K · filed 2025-03-10 | 34.23M shares derived: average of 2 quarters · filed 2025-03-10 | 30.64M shares derived: average of 3 quarters · filed 2025-03-10 | 28.83M shares 10-K · filed 2025-03-10 | |||
| 2023-09-30 | 32.30M shares 10-K · filed 2025-03-10 | 27.88M shares derived: average of 2 quarters · filed 2025-03-10 | 26.36M shares 10-K · filed 2025-03-10 | 25.53M shares derived: average of 4 quarters · filed 2025-03-10 | |||
| 2023-06-30 | 23.46M shares 10-K · filed 2025-03-10 | 23.37M shares 10-K · filed 2025-03-10 | 23.28M shares derived: average of 3 quarters · filed 2025-03-10 | 23.16M shares derived: average of 4 quarters · filed 2025-03-10 | |||
| 2023-03-31 | 23.28M shares 10-K · filed 2025-03-10 | 23.19M shares derived: average of 2 quarters · filed 2025-03-10 | 23.06M shares derived: average of 3 quarters · filed 2025-03-10 | 22.97M shares derived: average of 4 quarters · filed 2025-03-10 | |||
| 2022-12-31 | 23.09M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | 22.95M shares derived: average of 2 quarters · filed 2024-03-14 | 22.86M shares derived: average of 3 quarters · filed 2024-03-14 | 22.81M shares 10-K · filed 2024-03-14 | |||
| 2022-09-30 | 22.80M shares 10-Q · filed 2023-11-14 | 22.75M shares derived: average of 2 quarters · filed 2023-11-14 | 22.71M shares 10-Q · filed 2023-11-14 | 22.64M shares derived: average of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | 22.70M shares 10-Q · filed 2023-08-10 | 22.67M shares 10-Q · filed 2023-08-10 | 22.59M shares derived: average of 3 quarters · filed 2023-08-10 | 22.54M shares derived: average of 4 quarters · filed 2023-08-10 | |||
| 2022-03-31 | 22.63M shares 10-Q · filed 2023-05-11 | 22.53M shares derived: average of 2 quarters · filed 2023-05-11 | 22.48M shares derived: average of 3 quarters · filed 2023-05-11 | 22.44M shares derived: average of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | 22.43M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | 22.41M shares derived: average of 2 quarters · filed 2023-03-24 | 22.38M shares derived: average of 3 quarters · filed 2023-03-24 | 22.35M shares 10-K · filed 2023-03-24 | |||
| 2021-09-30 | 22.38M shares 10-Q · filed 2022-11-10 | 22.36M shares derived: average of 2 quarters · filed 2022-11-10 | 22.32M shares 10-Q · filed 2022-11-10 | ||||
| 2021-06-30 | 22.33M shares 10-Q · filed 2022-08-11 | 22.29M shares 10-Q · filed 2022-08-11 | |||||
| 2021-03-31 | 22.24M shares 10-Q · filed 2022-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B |